Cargando…

Analyzes In Silico Indicate the lncRNAs MIR31HG and LINC00939 as Possible Epigenetic Inhibitors of the Osteogenic Differentiation in PDLCs

Chromatin conformation, DNA methylation pattern, transcriptional profile, and non-coding RNAs (ncRNAs) interactions constitute an epigenetic pattern that influences the cellular phenotypic commitment and impacts the clinical outcomes in regenerative therapies. Here, we investigated the epigenetic la...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Rogério S., Assis, Rahyza I. F., Racca, Francesca, Bontempi, Ana Carolina, da Silva, Rodrigo A., Wiench, Malgorzata, Andia, Denise C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454380/
https://www.ncbi.nlm.nih.gov/pubmed/37628700
http://dx.doi.org/10.3390/genes14081649
_version_ 1785096179391922176
author Ferreira, Rogério S.
Assis, Rahyza I. F.
Racca, Francesca
Bontempi, Ana Carolina
da Silva, Rodrigo A.
Wiench, Malgorzata
Andia, Denise C.
author_facet Ferreira, Rogério S.
Assis, Rahyza I. F.
Racca, Francesca
Bontempi, Ana Carolina
da Silva, Rodrigo A.
Wiench, Malgorzata
Andia, Denise C.
author_sort Ferreira, Rogério S.
collection PubMed
description Chromatin conformation, DNA methylation pattern, transcriptional profile, and non-coding RNAs (ncRNAs) interactions constitute an epigenetic pattern that influences the cellular phenotypic commitment and impacts the clinical outcomes in regenerative therapies. Here, we investigated the epigenetic landscape of the SP7 transcriptor factor (SP7) and Distal-Less Homeobox 4 (DLX4) osteoblastic transcription factors (TFs), in human periodontal ligament mesenchymal cells (PDLCs) with low (l-PDLCs) and high (h-PDLCs) osteogenic potential. Chromatin accessibility (ATAC-seq), genome DNA methylation (Methylome), and RNA sequencing (RNA-seq) assays were performed in l- and h-PDLCs, cultured at 10 days in non-induced (DMEM) and osteogenic (OM) medium in vitro. Data were processed in HOMER, Genome Studio, and edgeR programs, and metadata was analyzed by online bioinformatics tools and in R and Python environments. ATAC-seq analyses showed the TFs genomic regions are more accessible in l-PDLCs than in h-PDLCs. In Methylome analyses, the TFs presented similar average methylation intensities (AMIs), without differently methylated probes (DMPs) between l- and h-PDLCs; in addition, there were no differences in the expression profiles of TFs signaling pathways. Interestingly, we identified the long non-coding RNAs (lncRNAs), MIR31HG and LINC00939, as upregulated in l-PDLCs, in both DMEM and OM. In the following analysis, the web-based prediction tool LncRRIsearch predicted RNA:RNA base-pairing interactions between SP7, DLX4, MIR31HG, and LINC00939 transcripts. The machine learning program TriplexFPP predicted DNA:RNA triplex-forming potential for the SP7 DNA site and for one of the LINC00939 transcripts (ENST00000502479). PCR data confirmed the upregulation of MIR31HG and LINC00939 transcripts in l-PDLCs (× h-PDLCs) in both DMEM and OM (p < 0.05); conversely, SP7 and DLX4 were downregulated, confirming those results observed in the RNA-Seq analysis. Together, these results indicate the lncRNAs MIR31HG and LINC00939 as possible epigenetic inhibitors of the osteogenic differentiation in PDLCs by (post)transcriptional and translational repression of the SP7 and DLX4 TFs.
format Online
Article
Text
id pubmed-10454380
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104543802023-08-26 Analyzes In Silico Indicate the lncRNAs MIR31HG and LINC00939 as Possible Epigenetic Inhibitors of the Osteogenic Differentiation in PDLCs Ferreira, Rogério S. Assis, Rahyza I. F. Racca, Francesca Bontempi, Ana Carolina da Silva, Rodrigo A. Wiench, Malgorzata Andia, Denise C. Genes (Basel) Article Chromatin conformation, DNA methylation pattern, transcriptional profile, and non-coding RNAs (ncRNAs) interactions constitute an epigenetic pattern that influences the cellular phenotypic commitment and impacts the clinical outcomes in regenerative therapies. Here, we investigated the epigenetic landscape of the SP7 transcriptor factor (SP7) and Distal-Less Homeobox 4 (DLX4) osteoblastic transcription factors (TFs), in human periodontal ligament mesenchymal cells (PDLCs) with low (l-PDLCs) and high (h-PDLCs) osteogenic potential. Chromatin accessibility (ATAC-seq), genome DNA methylation (Methylome), and RNA sequencing (RNA-seq) assays were performed in l- and h-PDLCs, cultured at 10 days in non-induced (DMEM) and osteogenic (OM) medium in vitro. Data were processed in HOMER, Genome Studio, and edgeR programs, and metadata was analyzed by online bioinformatics tools and in R and Python environments. ATAC-seq analyses showed the TFs genomic regions are more accessible in l-PDLCs than in h-PDLCs. In Methylome analyses, the TFs presented similar average methylation intensities (AMIs), without differently methylated probes (DMPs) between l- and h-PDLCs; in addition, there were no differences in the expression profiles of TFs signaling pathways. Interestingly, we identified the long non-coding RNAs (lncRNAs), MIR31HG and LINC00939, as upregulated in l-PDLCs, in both DMEM and OM. In the following analysis, the web-based prediction tool LncRRIsearch predicted RNA:RNA base-pairing interactions between SP7, DLX4, MIR31HG, and LINC00939 transcripts. The machine learning program TriplexFPP predicted DNA:RNA triplex-forming potential for the SP7 DNA site and for one of the LINC00939 transcripts (ENST00000502479). PCR data confirmed the upregulation of MIR31HG and LINC00939 transcripts in l-PDLCs (× h-PDLCs) in both DMEM and OM (p < 0.05); conversely, SP7 and DLX4 were downregulated, confirming those results observed in the RNA-Seq analysis. Together, these results indicate the lncRNAs MIR31HG and LINC00939 as possible epigenetic inhibitors of the osteogenic differentiation in PDLCs by (post)transcriptional and translational repression of the SP7 and DLX4 TFs. MDPI 2023-08-18 /pmc/articles/PMC10454380/ /pubmed/37628700 http://dx.doi.org/10.3390/genes14081649 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ferreira, Rogério S.
Assis, Rahyza I. F.
Racca, Francesca
Bontempi, Ana Carolina
da Silva, Rodrigo A.
Wiench, Malgorzata
Andia, Denise C.
Analyzes In Silico Indicate the lncRNAs MIR31HG and LINC00939 as Possible Epigenetic Inhibitors of the Osteogenic Differentiation in PDLCs
title Analyzes In Silico Indicate the lncRNAs MIR31HG and LINC00939 as Possible Epigenetic Inhibitors of the Osteogenic Differentiation in PDLCs
title_full Analyzes In Silico Indicate the lncRNAs MIR31HG and LINC00939 as Possible Epigenetic Inhibitors of the Osteogenic Differentiation in PDLCs
title_fullStr Analyzes In Silico Indicate the lncRNAs MIR31HG and LINC00939 as Possible Epigenetic Inhibitors of the Osteogenic Differentiation in PDLCs
title_full_unstemmed Analyzes In Silico Indicate the lncRNAs MIR31HG and LINC00939 as Possible Epigenetic Inhibitors of the Osteogenic Differentiation in PDLCs
title_short Analyzes In Silico Indicate the lncRNAs MIR31HG and LINC00939 as Possible Epigenetic Inhibitors of the Osteogenic Differentiation in PDLCs
title_sort analyzes in silico indicate the lncrnas mir31hg and linc00939 as possible epigenetic inhibitors of the osteogenic differentiation in pdlcs
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454380/
https://www.ncbi.nlm.nih.gov/pubmed/37628700
http://dx.doi.org/10.3390/genes14081649
work_keys_str_mv AT ferreirarogerios analyzesinsilicoindicatethelncrnasmir31hgandlinc00939aspossibleepigeneticinhibitorsoftheosteogenicdifferentiationinpdlcs
AT assisrahyzaif analyzesinsilicoindicatethelncrnasmir31hgandlinc00939aspossibleepigeneticinhibitorsoftheosteogenicdifferentiationinpdlcs
AT raccafrancesca analyzesinsilicoindicatethelncrnasmir31hgandlinc00939aspossibleepigeneticinhibitorsoftheosteogenicdifferentiationinpdlcs
AT bontempianacarolina analyzesinsilicoindicatethelncrnasmir31hgandlinc00939aspossibleepigeneticinhibitorsoftheosteogenicdifferentiationinpdlcs
AT dasilvarodrigoa analyzesinsilicoindicatethelncrnasmir31hgandlinc00939aspossibleepigeneticinhibitorsoftheosteogenicdifferentiationinpdlcs
AT wienchmalgorzata analyzesinsilicoindicatethelncrnasmir31hgandlinc00939aspossibleepigeneticinhibitorsoftheosteogenicdifferentiationinpdlcs
AT andiadenisec analyzesinsilicoindicatethelncrnasmir31hgandlinc00939aspossibleepigeneticinhibitorsoftheosteogenicdifferentiationinpdlcs